IMAB Surged Nearly 10% in Morning Trading for Considering A Stake Sale
Tiger Newspress2022-04-20
IMAB surged nearly 10% in morning trading for considering a stake sale.The company is working with advisers on strategic reviews upon receiving buyout interest from several US- and Europe-based pharmaceutical companies. It is also possible that the company would consider a stake sale linked to partnerships.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.